Carboxypeptidase-M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells

Granulomatous inflammations, characterized by the presence of activated macrophages (MAs) forming epithelioid cell (EPC) clusters, are usually easy to recognize. However, in ambiguous cases the use of a MA marker that expresses selectively in EPCs may be needed. Here, we report that carboxypeptidase-M (CPM), a MA-differentiation marker, is preferentially induced in EPCs of all granuloma types studied, but not in resting MAs. As CPM is not expressed constitutively in MAs, this allows utilization of CPM-immunohistochemistry in diagnostics of minute granuloma detection when dense non-granulomatous MAs are also present. Despite this rule, hardly any detectable CPM was found in advanced/active tubercle caseous disease, albeit in early tuberculosis granuloma, MAs still expressed CPM. Indeed, in vitro both the CPM-protein and -mRNA became downregulated when MAs were infected with live mycobacteria. In vitro, MA-CPM transcript is neither induced remarkably by interferon-γ, known to cause classical MA activation, nor by IL-4, an alternative MA activator. Instead, CPM is selectively expressed in lipid-laden MAs, including the foam cells of atherosclerotic plaques, xanthomatous lesions and lipid pneumonias. By using serum, rich in lipids, and low-density lipoprotein (LDL) or VLDL, CPM upregulation could be reproduced in vitro in monocyte-derived MAs both at transcriptional and protein levels, and the increase is repressed under lipid-depleted conditions. The microarray analyses support the notion that CPM induction correlates with a robust progressive increase in CPM gene expression during monocyte to MA maturation and dendritic cell (DC) differentiation mediated by granulocyte–MA-colony-stimulating factor+IL-4. M-CSF alone also induced CPM. These results collectively indicate that CPM upregulation in MAs is preferentially associated with increased lipid uptake, and exposure to CSF, features of EPCs, also. Therefore, CPM-immunohistochemistry is useful for granuloma and foam MA detections in tissue sections. Furthermore, the present data offer CPM for the first time to be a novel marker and cellular player in lipid uptake and/or metabolism of MAs by promoting foam cell formation

PPAR? nuclear receptor coupled arachidonic acid signaling is involved in differentiation and lipid production of human sebocytes

The transcriptional basis of sebocyte differentiation and lipid-producing mechanisms is mostly unclear. Peroxisome proliferator-activated receptor-gamma (PPAR?), a lipid activated transcription factor, has been implicated in lipid metabolism of various cell types. Here, we show that PPAR?? is differentially expressed in normal and pathological human sebocytes, and appears to have roles in their differentiation process. These were demonstrated in laser microdissected normal human sebaceous glands (SG) and SZ95 cells (immortalized sebocyte cell line) utilizing RT-qPCR, immunhistochemistry, for lipid analyses quantitative fluorimetry and mass spectrometry based analytical approaches. We have observed that PPAR? and its target genes, ADRP and PGAR, are expressed in and associated with the differentiation levels of sebocytes. Also, PPAR? is present in normal and hyperplastic SG, whereas its expression levels gradually decrease in cases obtained from SG adenoma and SG carcinoma cells, reflecting a maturation-linked expression pattern. Furthermore, in SZ95 sebocytes, natural lipids including arachidonic acid and arachidonic acid derivate keto-metabolites (e.g. 5-KETE, 12-KETE) appear to regulate PPAR? signaling pathways, which in turn modulate phospholipid biosynthesis and induce neutral lipid synthesis. Collectively, our findings highlight the importance of novel endogenous ligand-activated PPAR? signaling in human sebocyte biology and suggest that PPAR? might be a candidate target for the clinical management of SG disorder